+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genfit - logo

GENFIT is a biopharmaceutical company that focuses on developing diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. Its lead pipeline product elafibranor (GFT505) has recently completed a positive Phase 2b study in NASH (Non-Alcoholic Steato-Hepatitis). Genfit SA was founded in 1999 and is headquartered in Loos, France.

Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
Fatty Liver Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application - Product Thumbnail Image

Fatty Liver Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application

  • Report
  • February 2024
  • 102 Pages
  • Global
From
Primary Sclerosing Cholangitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Primary Sclerosing Cholangitis Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 99 Pages
  • Global
From
Liver Fibrosis Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Liver Fibrosis Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 105 Pages
  • Global
From
Tropifexor (Novartis/Pfizer) Drug Overview 2019 - Product Thumbnail Image

Tropifexor (Novartis/Pfizer) Drug Overview 2019

  • Report
  • July 2019
  • 13 Pages
  • Global
Acute On Chronic Liver Failure (ACLF) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Acute On Chronic Liver Failure (ACLF) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Elafibranor (Genfit) Drug Overview 2019 - Product Thumbnail Image

Elafibranor (Genfit) Drug Overview 2019

  • Report
  • July 2019
  • 15 Pages
  • Global
Acute On Chronic Liver Failure (ACLF) - Pipeline Insight, 2024 - Product Thumbnail Image

Acute On Chronic Liver Failure (ACLF) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Peroxisome Proliferator Activated Receptor Delta Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Peroxisome Proliferator Activated Receptor Delta Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 86 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2020 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1101 Pages
  • Global
From
Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Primary Biliary Cholangitis (Primary Biliary Cirrhosis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 149 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1300 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2029 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2029

  • Report
  • November 2020
  • 140 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1000 Pages
  • Global
From
Peroxisome Proliferator-Activated Receptor (PPAR) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Peroxisome Proliferator-Activated Receptor (PPAR) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Primary Biliary Cirrhosis - Pipeline Review, H1 2019 - Product Thumbnail Image

Primary Biliary Cirrhosis - Pipeline Review, H1 2019

  • Drug Pipelines
  • January 2019
  • 128 Pages
  • Global
From
Royalty Rates in Pharmaceutical and Biotechnology Deals - Product Thumbnail Image

Royalty Rates in Pharmaceutical and Biotechnology Deals

  • Report
  • March 2024
  • 500 Pages
  • Global
From
Non-Alcoholic Steatohepatitis (NASH): Dynamic Market Forecast to 2026 - Product Thumbnail Image

Non-Alcoholic Steatohepatitis (NASH): Dynamic Market Forecast to 2026

  • Report
  • September 2018
  • 56 Pages
  • Global
From
Nuclear Receptor ROR Gamma - Pipeline Review, H2 2019 - Product Thumbnail Image

Nuclear Receptor ROR Gamma - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 119 Pages
  • Global
From
Peroxisome Proliferator Activated Receptor Delta - Pipeline Review, H2 2019 - Product Thumbnail Image

Peroxisome Proliferator Activated Receptor Delta - Pipeline Review, H2 2019

  • Drug Pipelines
  • August 2019
  • 106 Pages
  • Global
From
Loading Indicator